aluates Reports

$ 0.0

Automative

Global Paclitaxel Drug-Eluting Balloon Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-15E14974

Global Paclitaxel Drug Eluting Balloon Market Research Report 2023

BUY CHAPTERS

Global Paclitaxel Drug-Eluting Balloon Market Research Report 2026

Code: QYRE-Auto-15E14974

Report

2026-01-23

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

B. Braun

Eurocor GmbH

Philips

Paclitaxel Drug-Eluting Balloon Market Size

The global Paclitaxel Drug-Eluting Balloon market was valued at US$ 1520 million in 2025 and is anticipated to reach US$ 3511 million by 2032, at a CAGR of 12.6% from 2026 to 2032.

Paclitaxel Drug-Eluting Balloon Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Paclitaxel Drug-Eluting Balloon competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on “leave nothing behind”: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.

Growth is shifting from “device substitution” toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves “from implants to repair.”

The main hurdle is no longer “does it work,” but “can it scale compliantly and sustainably.” Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny—making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.

Demand is moving toward “adjunct devices + repeatable technique.” Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the “leave nothing behind” value proposition.

Upstream differentiation is ultimately a coupled “materials + process chain” capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability—requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.

This report delivers a comprehensive overview of the global Paclitaxel Drug-Eluting Balloon market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Paclitaxel Drug-Eluting Balloon. The Paclitaxel Drug-Eluting Balloon market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Paclitaxel Drug-Eluting Balloon market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Paclitaxel Drug-Eluting Balloon manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Paclitaxel Drug-Eluting Balloon Market Report

Report Metric	Details
Report Name	Paclitaxel Drug-Eluting Balloon Market
Accounted market size in 2025	US$ 1520 million
Forecasted market size in 2032	US$ 3511 million
CAGR	12.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Peripheral DEB Coronary DEB
Segment by Use Scenario	In-Stent Restenosi De Novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Cardiac Catheterization Lab Hospital Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Paclitaxel Drug-Eluting Balloon manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Paclitaxel Drug-Eluting Balloon sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Paclitaxel Drug-Eluting Balloon Market growing?

Ans: The Paclitaxel Drug-Eluting Balloon Market witnessing a CAGR of 12.6% during the forecast period 2026-2032.

What is the Paclitaxel Drug-Eluting Balloon Market size in 2032?

Ans: The Paclitaxel Drug-Eluting Balloon Market size in 2032 will be US$ 3511 million.

Who are the main players in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The main players in the Paclitaxel Drug-Eluting Balloon Market are B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex

What are the Application segmentation covered in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The Applications covered in the Paclitaxel Drug-Eluting Balloon Market report are Cardiac Catheterization Lab, Hospital, Other

What are the Type segmentation covered in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The Types covered in the Paclitaxel Drug-Eluting Balloon Market report are Peripheral DEB, Coronary DEB

1 Paclitaxel Drug-Eluting Balloon Market Overview

1.1 Product Definition

1.2 Paclitaxel Drug-Eluting Balloon by Type

1.2.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Type: 2025 vs 2032

1.2.2 Peripheral DEB

1.2.3 Coronary DEB

1.3 Paclitaxel Drug-Eluting Balloon by Use Scenario

1.3.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De Novo

1.3.4 Small Vessel

1.4 Paclitaxel Drug-Eluting Balloon by Balloon Platform Mechanics

1.4.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 Paclitaxel Drug-Eluting Balloon by Application

1.5.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Application: 2025 vs 2032

1.5.2 Cardiac Catheterization Lab

1.5.3 Hospital

1.5.4 Other

1.6 Global Paclitaxel Drug-Eluting Balloon Market Size Estimates and Forecasts

1.6.1 Global Paclitaxel Drug-Eluting Balloon Revenue 2021–2032

1.6.2 Global Paclitaxel Drug-Eluting Balloon Sales 2021–2032

1.6.3 Global Paclitaxel Drug-Eluting Balloon Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Paclitaxel Drug-Eluting Balloon Market Competition by Manufacturers

2.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Manufacturers (2021–2026)

2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Paclitaxel Drug-Eluting Balloon, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Product Types and Applications

2.7 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Date of Entry into the Industry

2.8 Global Paclitaxel Drug-Eluting Balloon Market Competitive Situation and Trends

2.8.1 Global Paclitaxel Drug-Eluting Balloon Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Paclitaxel Drug-Eluting Balloon Players Market Share by Revenue

2.8.3 Global Paclitaxel Drug-Eluting Balloon Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Paclitaxel Drug-Eluting Balloon Market Scenario by Region

3.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2021–2032

3.2.1 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2021–2026

3.2.2 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2027–2032

3.3 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2021–2032

3.3.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2021–2026

3.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2027–2032

3.4 North America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country

3.4.1 North America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Paclitaxel Drug-Eluting Balloon Sales by Country (2021–2032)

3.4.3 North America Paclitaxel Drug-Eluting Balloon Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country

3.5.1 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2021–2032)

3.5.3 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Region

3.6.1 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (2021–2032)

3.6.3 Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country

3.7.1 Latin America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (2021–2032)

3.7.3 Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country

3.8.1 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2021–2032)

3.8.3 Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2021–2032)

4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2021–2026)

4.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2027–2032)

4.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021–2032)

4.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2021–2032)

4.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2021–2026)

4.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2027–2032)

4.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021–2032)

4.3 Global Paclitaxel Drug-Eluting Balloon Price by Type (2021–2032)

5 Segment by Application

5.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2021–2032)

5.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2021–2026)

5.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2027–2032)

5.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021–2032)

5.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2021–2032)

5.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2021–2026)

5.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2027–2032)

5.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2021–2032)

5.3 Global Paclitaxel Drug-Eluting Balloon Price by Application (2021–2032)

6 Key Companies Profiled

6.1 B. Braun

6.1.1 B. Braun Company Information

6.1.2 B. Braun Description and Business Overview

6.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolio

6.1.5 B. Braun Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 Boston Scientific

6.3.1 Boston Scientific Company Information

6.3.2 Boston Scientific Description and Business Overview

6.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolio

6.3.5 Boston Scientific Recent Developments/Updates

6.4 BD

6.4.1 BD Company Information

6.4.2 BD Description and Business Overview

6.4.3 BD Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 BD Paclitaxel Drug-Eluting Balloon Product Portfolio

6.4.5 BD Recent Developments/Updates

6.5 Yinyi Biotechnology

6.5.1 Yinyi Biotechnology Company Information

6.5.2 Yinyi Biotechnology Description and Business Overview

6.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product Portfolio

6.5.5 Yinyi Biotechnology Recent Developments/Updates

6.6 Acotec

6.6.1 Acotec Company Information

6.6.2 Acotec Description and Business Overview

6.6.3 Acotec Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Acotec Paclitaxel Drug-Eluting Balloon Product Portfolio

6.6.5 Acotec Recent Developments/Updates

6.7 Philips

6.7.1 Philips Company Information

6.7.2 Philips Description and Business Overview

6.7.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Philips Paclitaxel Drug-Eluting Balloon Product Portfolio

6.7.5 Philips Recent Developments/Updates

6.8 Lepu Medical

6.8.1 Lepu Medical Company Information

6.8.2 Lepu Medical Description and Business Overview

6.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Lepu Medical Paclitaxel Drug-Eluting Balloon Product Portfolio

6.8.5 Lepu Medical Recent Developments/Updates

6.9 Eurocor

6.9.1 Eurocor Company Information

6.9.2 Eurocor Description and Business Overview

6.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolio

6.9.5 Eurocor Recent Developments/Updates

6.10 MicroPort Medical

6.10.1 MicroPort Medical Company Information

6.10.2 MicroPort Medical Description and Business Overview

6.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product Portfolio

6.10.5 MicroPort Medical Recent Developments/Updates

6.11 Teleflex

6.11.1 Teleflex Company Information

6.11.2 Teleflex Description and Business Overview

6.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Teleflex Paclitaxel Drug-Eluting Balloon Product Portfolio

6.11.5 Teleflex Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Paclitaxel Drug-Eluting Balloon Industry Chain Analysis

7.2 Paclitaxel Drug-Eluting Balloon Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Paclitaxel Drug-Eluting Balloon Production Mode & Process Analysis

7.4 Paclitaxel Drug-Eluting Balloon Sales and Marketing

7.4.1 Paclitaxel Drug-Eluting Balloon Sales Channels

7.4.2 Paclitaxel Drug-Eluting Balloon Distributors

7.5 Paclitaxel Drug-Eluting Balloon Customer Analysis

8 Paclitaxel Drug-Eluting Balloon Market Dynamics

8.1 Paclitaxel Drug-Eluting Balloon Industry Trends

8.2 Paclitaxel Drug-Eluting Balloon Market Drivers

8.3 Paclitaxel Drug-Eluting Balloon Market Challenges

8.4 Paclitaxel Drug-Eluting Balloon Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

B. Braun

Eurocor GmbH

Philips

List of Tables

Table 1. Global Paclitaxel Drug-Eluting Balloon Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Paclitaxel Drug-Eluting Balloon Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global Paclitaxel Drug-Eluting Balloon Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global Paclitaxel Drug-Eluting Balloon Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Paclitaxel Drug-Eluting Balloon Market Competitive Situation by Manufacturers in 2025

Table 6. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Paclitaxel Drug-Eluting Balloon Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Paclitaxel Drug-Eluting Balloon Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Paclitaxel Drug-Eluting Balloon, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Product Types and Applications

Table 14. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Paclitaxel Drug-Eluting Balloon Companies by Tier (Tier 1, Tier 2, Tier 3), based on Paclitaxel Drug-Eluting Balloon Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Paclitaxel Drug-Eluting Balloon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Paclitaxel Drug-Eluting Balloon Sales by Region (K Units), 2021–2026

Table 20. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2021–2026)

Table 21. Global Paclitaxel Drug-Eluting Balloon Sales by Region (K Units), 2027–2032

Table 22. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2027–2032)

Table 23. Global Paclitaxel Drug-Eluting Balloon Revenue by Region (US$ Million), 2021–2026

Table 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2021–2026)

Table 25. Global Paclitaxel Drug-Eluting Balloon Revenue by Region (US$ Million), 2027–2032

Table 26. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2027–2032)

Table 27. North America Paclitaxel Drug-Eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2021–2026

Table 29. North America Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2027–2032

Table 30. North America Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 31. North America Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2021–2026

Table 34. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2027–2032

Table 35. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2021–2026

Table 44. Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2027–2032

Table 45. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 52. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Type (2021–2026)

Table 53. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Type (2027–2032)

Table 54. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021–2026)

Table 55. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2027–2032)

Table 56. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021–2026)

Table 59. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2027–2032)

Table 60. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2021–2026)

Table 61. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2027–2032)

Table 62. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Application (2021–2026)

Table 63. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Application (2027–2032)

Table 64. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021–2026)

Table 65. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2027–2032)

Table 66. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2021–2026)

Table 69. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2027–2032)

Table 70. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2021–2026)

Table 71. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2027–2032)

Table 72. B. Braun Company Information

Table 73. B. Braun Description and Business Overview

Table 74. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. B. Braun Paclitaxel Drug-Eluting Balloon Product

Table 76. B. Braun Recent Developments/Updates

Table 77. Medtronic Company Information

Table 78. Medtronic Description and Business Overview

Table 79. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Medtronic Paclitaxel Drug-Eluting Balloon Product

Table 81. Medtronic Recent Developments/Updates

Table 82. Boston Scientific Company Information

Table 83. Boston Scientific Description and Business Overview

Table 84. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Boston Scientific Paclitaxel Drug-Eluting Balloon Product

Table 86. Boston Scientific Recent Developments/Updates

Table 87. BD Company Information

Table 88. BD Description and Business Overview

Table 89. BD Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. BD Paclitaxel Drug-Eluting Balloon Product

Table 91. BD Recent Developments/Updates

Table 92. Yinyi Biotechnology Company Information

Table 93. Yinyi Biotechnology Description and Business Overview

Table 94. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product

Table 96. Yinyi Biotechnology Recent Developments/Updates

Table 97. Acotec Company Information

Table 98. Acotec Description and Business Overview

Table 99. Acotec Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Acotec Paclitaxel Drug-Eluting Balloon Product

Table 101. Acotec Recent Developments/Updates

Table 102. Philips Company Information

Table 103. Philips Description and Business Overview

Table 104. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Philips Paclitaxel Drug-Eluting Balloon Product

Table 106. Philips Recent Developments/Updates

Table 107. Lepu Medical Company Information

Table 108. Lepu Medical Description and Business Overview

Table 109. Lepu Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. Lepu Medical Paclitaxel Drug-Eluting Balloon Product

Table 111. Lepu Medical Recent Developments/Updates

Table 112. Eurocor Company Information

Table 113. Eurocor Description and Business Overview

Table 114. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. Eurocor Paclitaxel Drug-Eluting Balloon Product

Table 116. Eurocor Recent Developments/Updates

Table 117. MicroPort Medical Company Information

Table 118. MicroPort Medical Description and Business Overview

Table 119. MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 120. MicroPort Medical Paclitaxel Drug-Eluting Balloon Product

Table 121. MicroPort Medical Recent Developments/Updates

Table 122. Teleflex Company Information

Table 123. Teleflex Description and Business Overview

Table 124. Teleflex Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 125. Teleflex Paclitaxel Drug-Eluting Balloon Product

Table 126. Teleflex Recent Developments/Updates

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Paclitaxel Drug-Eluting Balloon Distributors List

Table 130. Paclitaxel Drug-Eluting Balloon Customers List

Table 131. Paclitaxel Drug-Eluting Balloon Market Trends

Table 132. Paclitaxel Drug-Eluting Balloon Market Drivers

Table 133. Paclitaxel Drug-Eluting Balloon Market Challenges

Table 134. Paclitaxel Drug-Eluting Balloon Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. Product Picture of Paclitaxel Drug-Eluting Balloon

Figure 2. Global Paclitaxel Drug-Eluting Balloon Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Paclitaxel Drug-Eluting Balloon Market Share by Type: 2025 & 2032

Figure 4. Peripheral DEB Product Picture

Figure 5. Coronary DEB Product Picture

Figure 6. Global Paclitaxel Drug-Eluting Balloon Market Value by Use Scenario (US$ Million), 2021–2032

Figure 7. Global Paclitaxel Drug-Eluting Balloon Market Share by Use Scenario: 2025 vs 2032

Figure 8. In-Stent Restenosi Product Picture

Figure 9. De Novo Product Picture

Figure 10. Small Vessel Product Picture

Figure 11. Global Paclitaxel Drug-Eluting Balloon Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 12. Global Paclitaxel Drug-Eluting Balloon Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 13. Semi-/Compliant Product Picture

Figure 14. Non-compliant Product Picture

Figure 15. Other Product Picture

Figure 16. Global Paclitaxel Drug-Eluting Balloon Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Paclitaxel Drug-Eluting Balloon Market Share by Application: 2025 & 2032

Figure 18. Cardiac Catheterization Lab

Figure 19. Hospital

Figure 20. Other

Figure 21. Global Paclitaxel Drug-Eluting Balloon Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Paclitaxel Drug-Eluting Balloon Market Size (US$ Million), 2021–2032

Figure 23. Global Paclitaxel Drug-Eluting Balloon Sales (K Units), 2021–2032

Figure 24. Global Paclitaxel Drug-Eluting Balloon Average Price (US$/Unit), 2021–2032

Figure 25. Paclitaxel Drug-Eluting Balloon Report Years Considered

Figure 26. Paclitaxel Drug-Eluting Balloon Sales Share by Manufacturers in 2025

Figure 27. Global Paclitaxel Drug-Eluting Balloon Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Paclitaxel Drug-Eluting Balloon Players: Market Share by Revenue in Paclitaxel Drug-Eluting Balloon in 2025

Figure 29. Paclitaxel Drug-Eluting Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Paclitaxel Drug-Eluting Balloon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021–2032)

Figure 32. North America Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 33. United States Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021–2032)

Figure 36. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 37. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2021–2032)

Figure 44. China Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021–2032)

Figure 52. Latin America Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021–2032)

Figure 57. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 58. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Saudi Arabia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. UAE Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Global Sales Market Share of Paclitaxel Drug-Eluting Balloon by Type (2021–2032)

Figure 62. Global Revenue Market Share of Paclitaxel Drug-Eluting Balloon by Type (2021–2032)

Figure 63. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2021–2032)

Figure 64. Global Sales Market Share of Paclitaxel Drug-Eluting Balloon by Application (2021–2032)

Figure 65. Global Revenue Market Share of Paclitaxel Drug-Eluting Balloon by Application (2021–2032)

Figure 66. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2021–2032)

Figure 67. Paclitaxel Drug-Eluting Balloon Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2024

Global Drug Eluting Balloon for Coronary Artery Disease Market Research Report 2025

Global Paclitaxel Coated Balloon Catheter Market Research Report 2024

Global Paclitaxel Coated PTA Balloon Catheter Market Research Report 2025

Global Drug Eluting Balloons DEB Market Insights Forecast to 2030

Global Drug Coated Balloon for Coronary Artery Disease Market Research Report 2025

Global Coronary Drug Coated Balloon Market Research Report 2025

Global Paclitaxel eluting Stent Market Insights Forecast to 2030

Drug Eluting Balloon Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Coated Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peripheral Scoring Drug eluting Balloon Dilation Catheter Market Research Report 2024

Global Paclitaxel Coated PTCA Balloon Catheter Market Research Report 2025

Global Peripheral Drug Eluting Stent Market Research Report 2025

Global PTA Drug Eluting Balloons Market Research Report 2025

Global Drug Coated Balloon for Peripheral Artery Diseases Market Research Report 2025

Global Drug Coated Coronary Balloon Dilatation Catheter Market Research Report 2024

Global Peripheral Drug Coated Balloon Market Research Report 2024

Global Drug Coated Coronary Balloon Catheter Market Research Report 2024

Global Peripheral Interventional Balloon Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions